{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T06:27:30Z","timestamp":1762928850090,"version":"3.44.0"},"reference-count":27,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2020,9,29]]},"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1136\/ejhpharm-2020-002387","type":"journal-article","created":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T17:20:29Z","timestamp":1603732829000},"page":"231-234","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome in a paediatric patient taking zonisamide"],"prefix":"10.1136","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9852-9874","authenticated-orcid":false,"given":"Ashifa","family":"Trivedi","sequence":"first","affiliation":[{"name":"Pharmacy Department, Hillingdon Hospitals NHS Foundation Trust, Uxbridge, Greater London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadhna","family":"Sharma","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Hillingdon Hospitals NHS Foundation Trust, Uxbridge, Greater London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranjith","family":"Govindan","sequence":"additional","affiliation":[{"name":"Paediatrics, Hillingdon Hospitals NHS Foundation Trust, Uxbridge, Greater London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,10,26]]},"reference":[{"key":"2025090702112730000_29.4.231.1","first-page":"31","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome","volume":"6","author":"Choudhary","year":"2013","journal-title":"J Clin Aesthet Dermatol"},{"key":"2025090702112730000_29.4.231.2","unstructured":"emc . Zonisamide 100mg hard capsules. Summary of Product Characteristics (SmPC)-(emc). Available: https:\/\/www.medicines.org.uk\/emc\/product\/10068\/smpc [Accessed 21 Apr 2020]."},{"key":"2025090702112730000_29.4.231.3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.29262\/ram.v61i1.16","article-title":"Prevalence of DRESS syndrome","volume":"61","author":"L\u00f3pez-Rocha","year":"2014","journal-title":"Rev Alerg Mex"},{"key":"2025090702112730000_29.4.231.4","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/PEC.0b013e31828a3854","article-title":"Pediatrician! Do you know the symptoms of DRESS syndrome? A case report of a 4-year-old girl","volume":"29","author":"Irga","year":"2013","journal-title":"Pediatr Emerg Care"},{"key":"2025090702112730000_29.4.231.5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2710.2009.01081.x","article-title":"DRESS-syndrome on sulfasalazine and naproxen treatment for juvenile idiopathic arthritis and reactivation of human herpevirus 6 in an 11-year-old Caucasian boy","volume":"35","author":"Pi\u00f1ana","year":"2010","journal-title":"J Clin Pharm Ther"},{"key":"2025090702112730000_29.4.231.6","doi-asserted-by":"publisher","DOI":"10.1177\/0009922808320703"},{"key":"2025090702112730000_29.4.231.7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.aller.2011.01.003","article-title":"Possible DRESS syndrome in a child with borreliosis","volume":"40","author":"Silva","year":"2012","journal-title":"Allergol Immunopathol"},{"key":"2025090702112730000_29.4.231.8","doi-asserted-by":"publisher","DOI":"10.1007\/BF01954091"},{"key":"2025090702112730000_29.4.231.9","doi-asserted-by":"crossref","first-page":"AB42","DOI":"10.1016\/j.jaci.2015.12.139","article-title":"A case report of DRESS with prolonged latency period related to zonisamide in a child","volume":"137","author":"Khan","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"2025090702112730000_29.4.231.10","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.12331"},{"key":"2025090702112730000_29.4.231.11","first-page":"1","article-title":"Successful treatment of antiepileptic drug-induced DRESS syndrome with pulse methylprednisolone","volume":"2013","author":"Kocaoglu","year":"2013","journal-title":"Case Rep Pediatr"},{"key":"2025090702112730000_29.4.231.12","doi-asserted-by":"crossref","DOI":"10.5070\/D3195018170","article-title":"Carbamazepine-induced DRESS syndrome in a child: rapid response to pulsed corticosteroids","volume":"19","author":"Teng","year":"2013","journal-title":"Dermatol Online J"},{"key":"2025090702112730000_29.4.231.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2011.01.017"},{"key":"2025090702112730000_29.4.231.14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07704.x"},{"key":"2025090702112730000_29.4.231.15","unstructured":"National Institute of Diabetes and Digestive and Kidney Diseases . LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. In: Adverse drug reaction probability scale (Naranjo) in drug induced liver injury. Bethesda (MD), 2019. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548069\/"},{"key":"2025090702112730000_29.4.231.16","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1310\/hpj5103-204","article-title":"Atorvastatin-induced fixed drug eruption clopidogrel-induced acute hepatitis bilateral angle-closure glaucoma induced by chlorthalidone risk of anaphylactic reactions with intravenous iron products zonisamide-induced DRESS with eosinophilic pneumonia","volume":"51","author":"Mancano","year":"2016","journal-title":"Hosp Pharm"},{"key":"2025090702112730000_29.4.231.17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2340\/00015555-1863","article-title":"DIHS\/DRESS with remarkable eosinophilic pneumonia caused by zonisamide","volume":"95","author":"Shibuya","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"2025090702112730000_29.4.231.18","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1468-3083.2012.04547.x","article-title":"Clinical course of drug-induced hypersensitivity syndrome treated without systemic corticosteroids","volume":"27","author":"Uhara","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025090702112730000_29.4.231.19","doi-asserted-by":"crossref","first-page":"no","DOI":"10.1111\/j.1346-8138.2010.01147.x","article-title":"Case of drug rash with eosinophilia and systemic symptoms induced by zonisamide and reactivation of human herpes virus 7","volume":"38","author":"Murata","year":"2011","journal-title":"J Dermatol"},{"key":"2025090702112730000_29.4.231.20","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2169\/internalmedicine.49.2451","article-title":"Acute kidney injury caused by zonisamide-induced hypersensitivity syndrome","volume":"49","author":"Fujita","year":"2010","journal-title":"Intern Med"},{"key":"2025090702112730000_29.4.231.21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2336\/nishinihonhifu.72.225","article-title":"Drug-Induced hypersensitivity syndrome (DINS) due to zonisamide (Excegran) showing only reactivation of cytomegalovirus","volume":"72","author":"Kyo","year":"2010","journal-title":"Nishi Nihon Hifuka"},{"key":"2025090702112730000_29.4.231.22","doi-asserted-by":"crossref","first-page":"584","DOI":"10.2336\/nishinihonhifu.71.584","article-title":"A case of drug-induced hypersensitivity syndrome with the features of toxic epidermal necrolysis","volume":"71","author":"Hirose","year":"2009","journal-title":"Nishi Nihon Hifuka"},{"key":"2025090702112730000_29.4.231.23","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2019.00474","article-title":"Fulminant type 1 diabetes mellitus caused by drug reaction with eosinophilia and systemic symptoms (DRESS): a case report and review of the literature","volume":"10","author":"Zhu","year":"2019","journal-title":"Front Endocrinol"},{"key":"2025090702112730000_29.4.231.24","doi-asserted-by":"crossref","DOI":"10.5812\/ircmj.36825","article-title":"Drug reaction with eosinophilia and systemic symptoms induced by valproic acid: a case report","volume":"18","author":"Darban","year":"2016","journal-title":"Iran Red Crescent Med J"},{"key":"2025090702112730000_29.4.231.25","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.jaip.2017.10.016","article-title":"Successful intravenous immunoglobulin treatment in pediatric severe DRESS syndrome","volume":"6","author":"Marcus","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2025090702112730000_29.4.231.26","article-title":"Immunomodulation by IVIg and the role of Fc-gamma receptors: classic mechanisms of action after all?","volume":"5","author":"Nagelkerke","year":"2014","journal-title":"Front Immunol"},{"key":"2025090702112730000_29.4.231.27","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jaip.2018.02.009","article-title":"Intravenous immunoglobulin may be beneficial as an add-on therapy in DRESS","volume":"6","author":"Giavina-Bianchi","year":"2018","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2020-002387","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T09:11:35Z","timestamp":1757236295000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2020-002387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,26]]},"references-count":27,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,6,23]]},"published-print":{"date-parts":[[2022,7]]}},"alternative-id":["10.1136\/ejhpharm-2020-002387"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2020-002387","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"type":"print","value":"2047-9956"},{"type":"electronic","value":"2047-9964"}],"subject":[],"published":{"date-parts":[[2020,10,26]]}}}